Nearly 8% of all prescriptions in March 2026 were for GLP-1 RAs, following the largest quarter-over-quarter percentage point increase in overall GLP-1 RA prescribing observed since the study began in 2019. First-time anti-obesity medication (AOM) prescribing increased...
Authors: Karen G Farrar ⊕University of Southern California, Los Angeles, CA, Duy Do ⊕Truveta, Inc, Bellevue, WA, Nina B Masters ⊕Truveta, Inc, Bellevue, WA, Brianna M Cartwright ⊕Truveta, Inc, Bellevue, WA After CVS Caremark made anti-obesity semaglutide the preferred...
Estrogen-based hormone replacement therapy (HRT) prescribing more than doubled from 2018 to 2026. The largest increases were seen in patches and vaginal creams, with patch use more than tripling and vaginal cream use increasing more than fourfold. The rates of women...
Four studies using Truveta Data examined real-world outcomes across diverse urology populations, spanning medical therapy, stone disease, oncology, and men’s health. The analyses identified differences in treatment patterns, safety, and outcomes not captured in...
